Remnant Cholesterol Inflammatory Index and Its Association With All‐Cause Mortality Among General Population and Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: Evidence From Two Nationwide Studies | Synapse
April 15, 2026Open Access
Remnant Cholesterol Inflammatory Index and Its Association With All‐Cause Mortality Among General Population and Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: Evidence From Two Nationwide Studies
Key Points
To investigate the predictive value of remnant cholesterol inflammatory index (RCII) for all-cause mortality in the general population and individuals with cardiovascular-kidney-metabolic syndrome stages 0-3.
Analyzed data from two nationwide studies
Examined the correlation between RCII and all-cause mortality
Included individuals across various CKM stages
RCII is identified as a strong and independent predictor of all-cause mortality
The association persists across diverse populations
Effectiveness of RCII as a health risk indicator is confirmed.
Abstract
RCII is a strong and independent predictor of all-cause mortality across diverse populations and CKM stages 0-3.